Evidence map›Paper›PMID 41450660›Full record

ReviewJACS Au2025

A Perspective on Unintentional Fragments and Their Impact on the Dark Metabolome, Untargeted Profiling, Molecular Networking, Public Data, and Repository Scale Analysis.

Yasin El Abiead, Ipsita Mohanty, Shipei Xing, Adriano Rutz, Vincent Charron-Lamoureux, Tito Damiani, Wenyun Lu, Gary J Patti, Nicola Zamboni, Oscar Yanes and 1 more

Abstract readReview
In one paragraph

Review in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Pan-Metabolomics Repository Mapping of the Carnitine Landscape.bioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yasin El AbieadSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, San Diego, California 92093-0751, United States.ORCID https://orcid.org/0000-0003-4392-7706
Ipsita MohantySkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, San Diego, California 92093-0751, United States.
Shipei XingSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, San Diego, California 92093-0751, United States.
Adriano RutzInstitute for Molecular Systems Biology, ETH Zurich, Otto-Stern-Weg 3, Zurich 8093, Switzerland.ORCID https://orcid.org/0000-0003-0443-9902
Vincent Charron-LamoureuxSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, San Diego, California 92093-0751, United States.
Tito DamianiDepartment of Biochemistry of Plant Specialized Metabolites, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo Náměstí 542/2, Prague 160 00, Czech Republic.ORCID https://orcid.org/0000-0002-4616-900X
Wenyun LuLewis Sigler Institute for Integrative Genomics and Department of Chemistry, Princeton University, Princeton, New Jersey 08544, United States.ORCID https://orcid.org/0000-0003-1787-2617
Gary J PattiDepartment of Chemistry, Genetics, and Medicine, and Center for Mass Spectrometry and Metabolic Tracing, Washington University, St. Louis, Missouri 63110, United States.ORCID https://orcid.org/0000-0002-3748-6193
Nicola ZamboniInstitute for Molecular Systems Biology, ETH Zurich, Otto-Stern-Weg 3, Zurich 8093, Switzerland.
Oscar YanesDepartment of Electronic Engineering & IISPV, Universitat Rovira i Virgili, Tarragona 43007, Spain.ORCID https://orcid.org/0000-0003-3695-7157
Pieter C DorresteinSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, San Diego, California 92093-0751, United States.ORCID https://orcid.org/0000-0002-3003-1030

Funding

Collaborative Microbial Metabolite CenterU24DK133658 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PIETER C DORRESTEIN · 2022 to 2026
$2.9M
Revealing cancer metabolism via mass spectrometry and isotope tracersR50CA211437 · NCI · PRINCETON UNIVERSITY · PI Wenyun Lu · 2016 to 2026
$1.3M
NCI NIH HHS R50 CA211437NIDDK NIH HHS U24 DK133658
6 · The paper itself

Abstract

In/postsource fragments (ISFs) arise during electrospray ionization or ion transfer in mass spectrometry when molecular bonds break, generating ions that can complicate data interpretation. Although ISFs have been recognized for decades, their contribution to untargeted metabolomicsparticularly in the context of the so-called "dark matter" (unannotated MS or MS/MS spectra) and the "dark metabolome" (unannotated molecules)remains unsettled. This ongoing debate reflects a central tension: while some caution against overinterpreting unidentified signals lacking biological evidence, others argue that dismissing them too quickly risks overlooking genuine molecular discoveries. These discussions also raise a deeper question: what exactly should be considered part of the metabolome? As metabolomics advances toward large-scale data mining and high-throughput computational analysis, resolving these conceptual and methodological ambiguities has become essential. In this perspective, we propose a refined definition of the "dark metabolome" and present a systematic overview of ISFs and related ion forms, including adducts and multimers. We examine their impact on metabolite annotation, experimental design, statistical analysis, computational workflows, and repository-scale data mining. Finally, we provide practical recommendationsincluding a set of dos and do nots for researchers and reviewersand discuss the broader implications of ISFs for how the field explores unknown molecular space. By embracing a more nuanced understanding of ISFs, metabolomics can achieve greater rigor, reduce misinterpretation, and unlock new opportunities for discovery.

Indexed as

analytical artifactdark metabolomeelectrospray ionizationin-source fragmentationmass spectrometrymetabolomics

Identifiers

PMID41450660
PMCPMC12728610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.